Rotigotine Transdermal Patch for the Treatment of Restless Legs Syndrome

Publisher： Karger

E-ISSN： 2296-7362|1|1|32-43

ISSN： 2296-7362

Source： Integrative Medicine International, Vol.1, Iss.1, 2014-05, pp. : 32-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of licensed treatment options for restless legs syndrome in the UK and Sweden

By Lees M.   Roberts G.   Tabberer M.   DasGupta R.   Finnern H. W.    

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2919-2930

Informa Healthcare

Access to resources Recommend Favorite

The powerful pre‐treatment effect: placebo responses in restless legs syndrome trials

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 19, Iss. 10, 2012-10 ,pp. : 1305-1310

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulations

By Elshoff Jan-Peer   Timmermann Lars   Schmid Miriam   Arth Christoph   Komenda Michael   Brunnert Marcus   Bauer Lars  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1657-1662

Informa Healthcare

Access to resources Recommend Favorite

Risk Factors for Restless Legs Syndrome in Dialysis Patients

By  

Nephron Clin Pract, Vol. 101, Iss. 3, 2005-07 ,pp. : c155-c160

Karger

Access to resources Recommend Favorite

Plasma copeptin levels in patients with restless legs syndrome

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 137, Iss. 3, 2018-03 ,pp. : 316-320

John Wiley & Sons Inc

Access to resources Recommend Favorite